The effect of hemoperfusion on the recovery of COVID-19 in hospitalized patients; case series and review study

被引：1

作者：

Hajian, Sepideh ^{[1
]}

Rastgoo, Nafiseh ^{[2
]}

机构：

[1] Qazvin Univ Med Sci, Velayat Hosp, Dept Nephrol, Qazvin, Iran

[2] Qazvin Univ Med Sci, Student Res Comm, Qazvin, Iran

来源：

IMMUNOPATHOLOGIA PERSA | 2021年 / 7卷 / 02期

关键词：

Hemoperfusion; COVID-19; Novel coronavirus; Clinical symptoms; CORONAVIRUS COVID-19; HEMODIALYSIS;

D O I：

10.34172/ipp.2021.13

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Hemoperfusion is an effective modality in removing certain toxins from the blood, especially those that bind to proteins in the body. Hemoperfusion has shown a therapeutic effect on COVID-19 patients. In this case series, we report four patients without effective results following the use of hemoperfusion on the recovery of COVID-19 patients. This study is a case series which carried out on four patients referred to COVID-19 ward of Velayat hospital in Qazvin, Iran. The mean age of the COVID-19 patients was 52.75 +/- 18 years. The mean stay at the hospital was 21.5 +/- 15.15 days. This study showed that hemoperfusion cannot show a significant therapeutic effect on COVID-19.

引用

页数：4

共 17 条

[1]

Al-Dadah O, 2020, KNEE, V27, P279, DOI 10.1016/j.knee.2020.04.003

[2] Septic shock [J].

Annane, D ;

Bellissant, E ;

Cavaillon, JM .

LANCET, 2005, 365 (9453) :63-78

[3] High-volume haemofiltration for sepsis [J].

Borthwick, Emma M. J. ;

Hill, Christopher J. ;

Rabindranath, Kannaiyan S. ;

Maxwell, Alexander P. ;

McAuley, Danny F. ;

Blackwood, Bronagh .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (01)

[4] Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock The EUPHAS Randomized Controlled Trial [J].

Cruz, Dinna N. ;

Antonelli, Massimo ;

Fumagalli, Roberto ;

Foltran, Francesca ;

Brienza, Nicola ;

Donati, Abele ;

Malcangi, Vincenzo ;

Petrini, Flavia ;

Volta, Giada ;

Pallavicini, Franco M. Bobbio ;

Rottoli, Federica ;

Giunta, Francesco ;

Ronco, Claudio .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (23) :2445-2452

[5] Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry [J].

Cutuli, Salvatore Lucio ;

Artigas, Antonio ;

Fumagalli, Roberto ;

Monti, Gianpaola ;

Ranieri, Vito Marco ;

Ronco, Claudio ;

Antonelli, Massimo .

ANNALS OF INTENSIVE CARE, 2016, 6

[6] Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19 [J].

Dastan, Farzaneh ;

Saffaei, Ali ;

Mortazavi, Seyed Mehdi ;

Jamaati, Hamidreza ;

Adnani, Nadia ;

Roudi, Sasan Samiee ;

Kiani, Arda ;

Abedini, Atefeh ;

Hashemian, Seyed MohammadReza .

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 21 :340-341

[7]

Forouzesh M, 2020, EUR REV MED PHARMACO, V24, P4607, DOI 10.26355/eurrev_202004_21047

[8] COVID-19 Infection in a Patient with End-Stage Kidney Disease [J].

Fu, Dian ;

Yang, Bo ;

Xu, Jing ;

Mao, Zhiguo ;

Zhou, Chenchen ;

Xue, Cheng .

NEPHRON, 2020, 144 (05) :245-247

[9] HEMOPERFUSION FOR ACUTE INTOXICATIONS - CON [J].

GARELLA, S ;

LORCH, JA .

CLINICAL TOXICOLOGY, 1980, 17 (04) :515-527

[10] Use of hemodialysis and hemoperfusion in poisoned patients [J].

Holubek, William J. ;

Hoffman, Robert S. ;

Goldfarb, David S. ;

Nelson, Lewis S. .

KIDNEY INTERNATIONAL, 2008, 74 (10) :1327-1334

← 1 2 →